| Page 1742 | Kisaco Research
 

Gayathri Radhakrishnan

Partner
Hitachi Ventures

Gayathri is currently Partner at Hitachi Ventures. Prior to that, she was with Micron Ventures, actively investing in startups that apply AI to solve critical problems in the areas of Manufacturing, Healthcare and Automotive. She brings over 20 years of multi-disciplinary experience across product management, product marketing, corporate strategy, M&A and venture investments in large Fortune 500 companies such as Dell and Corning and in startups. She has also worked as an early stage investor at Earlybird Venture Capital, a premier European venture capital fund based in Germany.

Gayathri Radhakrishnan

Partner
Hitachi Ventures

Gayathri Radhakrishnan

Partner
Hitachi Ventures

Gayathri is currently Partner at Hitachi Ventures. Prior to that, she was with Micron Ventures, actively investing in startups that apply AI to solve critical problems in the areas of Manufacturing, Healthcare and Automotive. She brings over 20 years of multi-disciplinary experience across product management, product marketing, corporate strategy, M&A and venture investments in large Fortune 500 companies such as Dell and Corning and in startups. She has also worked as an early stage investor at Earlybird Venture Capital, a premier European venture capital fund based in Germany. She has a Masters in EE from The Ohio State University and MBA from INSEAD in France. She is also a Kauffman Fellow - Class 16.

 

Mike Indursky

Founder
Hear Me Raw

Mike Indursky

Founder
Hear Me Raw

Mike Indursky

Founder
Hear Me Raw
Sponsor a Webinar
Making Microbiome-modulating Therapeutics a reality
 

Marc St. Onge

Founder
Bend Beauty

Marc St. Onge

Founder
Bend Beauty

Marc St. Onge

Founder
Bend Beauty
 

Jennifer Backman

Director of Business Development
Bend Beauty

Jennifer Backman

Director of Business Development
Bend Beauty

Jennifer Backman

Director of Business Development
Bend Beauty
 

Giorgio Galli

Lab Head Target Identification & Validation,
NIBR, Novartis

Giorgio Galli

Lab Head Target Identification & Validation,
NIBR, Novartis

Giorgio Galli

Lab Head Target Identification & Validation,
NIBR, Novartis
 

Christopher Ott

Principal Investigator, Center for Cancer Research
Massachusetts General Hospital

Christopher Ott

Principal Investigator, Center for Cancer Research
Massachusetts General Hospital

Christopher Ott

Principal Investigator, Center for Cancer Research
Massachusetts General Hospital
 

Will West

Founder & Chief Executive Officer
CellCentric

Will West

Founder & Chief Executive Officer
CellCentric

Will West

Founder & Chief Executive Officer
CellCentric